Large-scale QSAR study of aromatase inhibitors using SMILES-based descriptors

Abstract Aromatase inhibitors (AIs) represent a promising therapeutic class of anticancer agents against estrogen receptor-positive breast cancer. Bioactivity data on pIC 50 of 973 AIs were employed in the construction of quantitative structure-activity relationship (QSAR) models using COR relation And Logic (CORAL) software ( http://www.insilico.eu/coral ) in which molecular structures are represented by the simplified molecular input line entry system (SMILES) notation. Symbols inherently present in SMILES nomenclatures describe the presence of molecular fragments and therefore represent a facile approach that essentially eliminate the need to geometrically optimize molecular structures or the hassle of computing and selecting molecular descriptors. Predictive models were built in accordance with the OECD principles. Monte Carlo optimization of correlation weights of such molecular fragments provides pertinent information on structural constituents for correlating with the aromatase inhibitory activity. Results from different splits and data sub-sets indicated reliable models for predicting and interpreting the origins of aromatase inhibitory activities with the correlation coefficient ( R 2 ) and cross-validated correlation coefficient ( Q 2 ) in ranges of 0.6271–0.7083 and 0.6218–0.7024, respectively. Insights gained from constructed models could aid in the future design of aromatase inhibitors.

[1]  Jerzy Leszczynski,et al.  CORAL: QSPR model of water solubility based on local and global SMILES attributes. , 2013, Chemosphere.

[2]  A. Toropova,et al.  QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method. , 2014, European journal of medicinal chemistry.

[3]  Komal Sharma,et al.  A PRACTICAL OVERVIEW OF QUANTITATIVE STRUCTURE- ACTIVITY RELATIONSHIP , 2016 .

[4]  Apilak Worachartcheewan,et al.  QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole. , 2013, European journal of medicinal chemistry.

[5]  P. Brown,et al.  Aromatase inhibitors and breast cancer prevention , 2012, Expert opinion on pharmacotherapy.

[6]  Angelo D. Favia,et al.  Computational methods for the design of potent aromatase inhibitors , 2013, Expert opinion on drug discovery.

[7]  P. Achary,et al.  Simplified molecular input line entry system-based optimal descriptors: QSAR modelling for voltage-gated potassium channel subunit Kv7.2 , 2014, SAR and QSAR in environmental research.

[8]  Kunal Roy,et al.  Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors , 2010, Journal of molecular modeling.

[9]  Kaki Venkata Rao,et al.  Molecular Modeling Evaluation of Non‐Steroidal Aromatase Inhibitors † , 2012, Chemical biology & drug design.

[10]  Eduardo A. Castro,et al.  QSAR Study and Molecular Design of Open-Chain Enaminones as Anticonvulsant Agents , 2011, International journal of molecular sciences.

[11]  Giuseppina C. Gini,et al.  CORAL: Quantitative structure–activity relationship models for estimating toxicity of organic compounds in rats , 2011, J. Comput. Chem..

[12]  Emilio Benfenati,et al.  Additive SMILES-Based Carcinogenicity Models: Probabilistic Principles in the Search for Robust Predictions , 2009, International journal of molecular sciences.

[13]  Eduardo A. Castro,et al.  QSAR on aryl-piperazine derivatives with activity on malaria , 2012 .

[14]  Pablo R Duchowicz,et al.  A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases. , 2011, Journal of molecular graphics & modelling.

[15]  Apilak Worachartcheewan,et al.  Exploring the chemical space of aromatase inhibitors , 2013, Molecular Diversity.

[16]  Y. Uesawa,et al.  Quantitative structure-activity relationship (QSAR) analysis of tumor-specificity of 1,2,3,4-tetrahydroisoquinoline derivatives. , 2011, Anticancer research.

[17]  Andrey A Toropov,et al.  QSAR models for anti-malarial activity of 4-aminoquinolines. , 2014, Current computer-aided drug design.

[18]  Paola Gramatica,et al.  The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .

[19]  Apilak Worachartcheewan,et al.  QSAR Study of H1N1 Neuraminidase Inhibitors from Influenza a Virus , 2014 .

[20]  C. Nantasenamat,et al.  QSAR modeling of aromatase inhibition by flavonoids using machine learning approaches , 2014, Chemical Papers.

[21]  C. Nantasenamat,et al.  QSAR study of amidino bis-benzimidazole derivatives as potent anti-malarial agents against Plasmodium falciparum , 2013, Chemical Papers.

[22]  Giuseppina C. Gini,et al.  Coral: QSPR modeling of rate constants of reactions between organic aromatic pollutants and hydroxyl radical , 2012, J. Comput. Chem..

[23]  Jerzy Leszczynski,et al.  Novel application of the CORAL software to model cytotoxicity of metal oxide nanoparticles to bacteria Escherichia coli. , 2012, Chemosphere.

[24]  G. Gini,et al.  QSAR models for inhibitors of physiological impact of Escherichia coli that leads to diarrhea. , 2013, Biochemical and biophysical research communications.

[25]  Chartchalerm Isarankura-Na-Ayudhya,et al.  Molecular Docking of Aromatase Inhibitors , 2011, Molecules.

[26]  Erik Johansson,et al.  Multivariate design and modeling in QSAR , 1996 .

[27]  Giuseppina C. Gini,et al.  Coral: QSAR models for acute toxicity in fathead minnow (Pimephales promelas) , 2012, J. Comput. Chem..

[28]  A. Foroumadi,et al.  QSAR Study of 4‐Aryl‐4H‐Chromenes as a New Series of Apoptosis Inducers Using Different Chemometric Tools , 2012, Chemical biology & drug design.

[29]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[30]  Chartchalerm Isarankura-Na-Ayudhya,et al.  Advances in computational methods to predict the biological activity of compounds , 2010, Expert opinion on drug discovery.

[31]  G. N. Sastry,et al.  Aromatase inhibitors: a new paradigm in breast cancer treatment. , 2004, Current medicinal chemistry. Anti-cancer agents.

[32]  Andrey A Toropov,et al.  CORAL software: prediction of carcinogenicity of drugs by means of the Monte Carlo method. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[33]  Apilak Worachartcheewan,et al.  Predicting the free radical scavenging activity of curcumin derivatives , 2011 .

[34]  Kunal Roy,et al.  Comparative QSARs for antimalarial endochins: Importance of descriptor-thinning and noise reduction prior to feature selection , 2011 .

[35]  E Benfenati,et al.  CORAL: classification model for predictions of anti-sarcoma activity. , 2012, Current topics in medicinal chemistry.

[36]  Eduardo A. Castro,et al.  QSAR treatment on a new class of triphenylmethyl-containing compounds as potent anticancer agents , 2011 .